![]() ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. | ![]() Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | ![]() Apic Bio Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2002 | Founding Date 2017 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations København, DK HQ Cary, US Cary, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 1,869 | Employees 54 | Employees 6 |
Financial | |||
Revenue (est.) | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods $190.5m (FY, 2025) | Cost of goods kr7.9m (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit $269.6m (FY, 2025) | Gross profit kr31.6m (FY, 2018) | Gross profit N/A |
Net income | Net income ($175.5m) (FY, 2025) | Net income (kr5.3m) (FY, 2018) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 985m | Total funding raised $ 60m | Total funding raised $ 51m |

Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company
Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases.
View company